Package 0002-3115-00

Generic: galcanezumab-gnlm
NDC Package

Package Facts

Identity

Package NDC 0002-3115-00
Digits Only 0002311500
Product NDC 0002-3115
Product ID 0002-3115_368df5d9-5eeb-49c7-a0dd-8a326ee5d78f
Description

1 mL in 1 SYRINGE (0002-3115-00)

Marketing

Marketing Status
Marketed Since 2019-06-04
Generic galcanezumab-gnlm

Linked Drug Pages (0)

No linked drugs yet.

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "368df5d9-5eeb-49c7-a0dd-8a326ee5d78f", "openfda": {}, "finished": false, "packaging": [{"description": "1 mL in 1 SYRINGE (0002-3115-00)", "package_ndc": "0002-3115-00", "marketing_start_date": "04-JUN-19"}], "product_id": "0002-3115_368df5d9-5eeb-49c7-a0dd-8a326ee5d78f", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "0002-3115", "generic_name": "galcanezumab-gnlm", "labeler_name": "Eli Lilly and Company", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "GALCANEZUMAB", "strength": "100 mg/mL"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20190604", "listing_expiration_date": "20261231"}